Skip to main content
. 2011 Oct 10;73(3):391–401. doi: 10.1111/j.1365-2125.2011.04108.x

Figure 4.

Figure 4

Simulations showing indicated model components vs. time for the three doses of vildagliptin. Vildagliptin central (ng ml−1) (Inline graphic); DPP4 activity central (mU ml−1min) (Inline graphic); Vildagliptin peripheral (nmol) (Inline graphic); Vilda-DPP4 complex central (nmol) (Inline graphic); Vilda-DPP4 complex peripheral (nmol) (Inline graphic)